Clinical Trial Update: Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a multivalent conjugate vaccine in biochemically relapsed prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate, Cancer | Phase 2 | Status: COMPLETED